Alice Mège

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Genomics to select treatment for patients with metastatic breast cancer

Fabrice André, Thomas Filleron, Maud Kamal et al. · Nature · 2022 · 168 citations

Medicine, Bioinformatics, Oncology +12

Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial

Thomas Bachelot, Thomas Filleron, Ivan Bièche et al. · Nature Medicine · 2021 · 158 citations

Medicine, Oncology, Pharmacology +9

Impact of Intensity-Modulated Radiotherapy on Health-Related Quality of Life for Head and Neck Cancer Patients: Matched-Pair Comparison with Conventional Radiotherapy

P. Gräff, M. Lapeyre, Emmanuel Désandes et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 132 citations

Medicine, Oncology, Radiation Oncology +17

Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control

L. Tournier-Rangeard, M. Lapeyre, Pierre Graff-Caillaud et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 97 citations

Medicine, Oncology, Radiation Oncology +8